{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:49:18Z","timestamp":1756993758101},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1989,11,1]],"date-time":"1989-11-01T00:00:00Z","timestamp":625881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1989,11]]},"DOI":"10.1007\/bf00445568","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T08:56:44Z","timestamp":1100163404000},"page":"409-415","source":"Crossref","is-referenced-by-count":15,"title":["CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats"],"prefix":"10.1007","volume":"99","author":[{"given":"F.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ettenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. F.","family":"Koob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/BF01120202","volume":"3","author":"LF Agnati","year":"1983","unstructured":"Agnati LF, Fuxe K (1983) Subcortical limbic 3H-N-propylnorapomorphine binding sites are markedly modulated by cholecystokinin-8 in vitro. Biosci Rep 3:1101?1105","journal-title":"Biosci Rep"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1749-6632.1985.tb29927.x","volume":"448","author":"LF Agnati","year":"1985","unstructured":"Agnati LF, Fuxe K, Giardino L, Calza L, Zoli M, Battistini F, Benfenati F, Vanderhaegen J-J, Guidolin D, Ruggeri M, Goldstein M (1985) Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Ann NY Acad Sci 448:315?333","journal-title":"Ann NY Acad Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-0115(87)90053-X","volume":"17","author":"CD Blaha","year":"1987","unstructured":"Blaha CD, Phillips AG, Lane RF (1987) Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat. Regul Pept 17:301?310","journal-title":"Regul Pept"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"DR Burt","year":"1977","unstructured":"Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326?328","journal-title":"Science"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0024-3205(83)90224-2","volume":"32","author":"RSL Chang","year":"1983","unstructured":"Chang RSL, Lotti VJ, Martin GE, Chen TB (1983) Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions. Life Sci 32:871?878","journal-title":"Life Sci"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-2999(82)90254-0","volume":"83","author":"SL Cohen","year":"1982","unstructured":"Cohen SL, Knight M, Tamminga CA, Chase T (1982) Cholecystokinin-octapeptide effects on conditioned avoidance behavior, stereotypy and catalepsy. Eur J Pharmacol 83:213?222","journal-title":"Eur J Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(85)90489-5","volume":"335","author":"JN Crawley","year":"1985","unstructured":"Crawley JN, Hommer DW, Skirbol LR (1985a) Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat. Brain Res 335:337?341","journal-title":"Brain Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1523\/JNEUROSCI.05-08-01972.1985","volume":"5","author":"JN Crawley","year":"1985","unstructured":"Crawley JN, Stivers JA, Blumstein LK, Paul SM (1985b) Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. J Neurosci 5:1972?1983","journal-title":"J Neurosci"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF00432676","volume":"74","author":"AJ Cross","year":"1981","unstructured":"Cross AJ, Crow TJ, Owen F (1981) 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors. Psychopharmacology 74:122?124","journal-title":"Psychopharmacology"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0196-9781(84)90040-8","volume":"5","author":"JF DeFrance","year":"1984","unstructured":"DeFrance JF, Sikes RW, Chronister RB (1984) The effects of CCK-8 in the nucleus accumbens. Peptides 5:1?6","journal-title":"Peptides"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0091-3057(83)90400-8","volume":"19","author":"HE Ellinwood Jr","year":"1983","unstructured":"Ellinwood HE Jr, Rockwell WJK, Wagoner N (1983) A caeruleinsensitive potentiation of the behavioral effects of apomorphine by dibutyryl-c-AMP. Pharmacol Biochem Behav 19:969?971","journal-title":"Pharmacol Biochem Behav"},{"key":"CR12","first-page":"39","volume":"58","author":"M Fekete","year":"1981","unstructured":"Fekete M, Szabo A, Balazs M, Penke B, Telegdy G (1981) Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behavior of rats. Acta Physiol Acad Sci Hung 58:39?45","journal-title":"Acta Physiol Acad Sci Hung"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-2999(83)90364-3","volume":"91","author":"M Fekete","year":"1983","unstructured":"Fekete M, Rentzsch A, Schwarzberg H, Telegdy G (1983) Effects of cholecystokinin on self-stimulation behavior in rats. Eur J Pharmacol 91:77?82","journal-title":"Eur J Pharmacol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-2999(83)90270-4","volume":"95","author":"P Frey","year":"1983","unstructured":"Frey P (1983) Cholecystokinin octapeptide levels in rat brain are changed after subchronic neuroleptic treatment. Eur J Pharmacol 95:87?92","journal-title":"Eur J Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0143-4179(84)90117-3","volume":"4","author":"K Gysling","year":"1984","unstructured":"Gysling K, Beinfeld MC (1984) Failure of chronic haloperidol treatment to alter levels of cholecystokinin in the rat brain striatum and olfactory tubercle-nucleus accumbens area. Neuropeptides 4:421?423","journal-title":"Neuropeptides"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/285476a0","volume":"238","author":"T H\u00f6kfelt","year":"1980","unstructured":"H\u00f6kfelt T, Rehfeld JF, Skirbol L, Ivemark B, Goldstein M, Markey K (1980a) Evidence for coexistence of dopamine and CCK in meso-limbic neurons. Nature 238:476?478","journal-title":"Nature"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/0306-4522(80)90127-X","volume":"5","author":"T H\u00f6kfelt","year":"1980","unstructured":"H\u00f6kfelt T, Skirbol L, Rehfeld JF, Goldstein M, Markey K, Dann O (1980b) A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contain cholecystokinin-like peptide. Neuroscience 5:2093?2124","journal-title":"Neuroscience"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(83)90380-1","volume":"91","author":"DW Hommer","year":"1983","unstructured":"Hommer DW, Skirbol LR (1983) Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons. Eur J Pharmacol 91:151?152","journal-title":"Eur J Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.1984.01790170091010","volume":"41","author":"DW Hommer","year":"1984","unstructured":"Hommer DW, Pickar D, Roy A, Ninan P, Boronow J, Paul SM (1984) The effects of ceruletide in schizophrenia. Arch Gen Psychiatry 41:617?619","journal-title":"Arch Gen Psychiatry"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(81)90559-8","volume":"75","author":"S Itoh","year":"1981","unstructured":"Itoh S, Katsuura G (1981) Suppressive action of cholecystokinin octapeptide on the behavioral effects of l-dopa in the rat. Eur J Pharmacol 75:313?316","journal-title":"Eur J Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00426456","volume":"73","author":"EM Joyce","year":"1981","unstructured":"Joyce EM, Koob GF (1981) Amphetamine-, scopolamine-, and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine systems. Psychopharmacology 73:311?313","journal-title":"Psychopharmacology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0028-3908(84)90104-7","volume":"23","author":"G Katsuura","year":"1984","unstructured":"Katsuura G, Itoh S, Rehfeld JF (1984) Effects of cholecystokinin on apomorphine-induced changes of motility in rats. Neuropharmacology 23:731?734","journal-title":"Neuropharmacology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0196-9781(85)90082-8","volume":"6","author":"G Katsuura","year":"1985","unstructured":"Katsuura G, Itoh S, Hsiao S (1985) Specificity of nucleus accumbens to activities related to cholecystokinin in rats. Peptides 6:91?96","journal-title":"Peptides"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0091-3057(83)90322-2","volume":"19","author":"PH Kelly","year":"1983","unstructured":"Kelly PH, Roberts DCS (1983) Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi. Pharmacol Biochem Behav 19:137?143","journal-title":"Pharmacol Biochem Behav"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","volume":"94","author":"PH Kelly","year":"1975","unstructured":"Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507?522","journal-title":"Brain Res"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/ajp.137.2.191","volume":"137","author":"T Lee","year":"1980","unstructured":"Lee T, Seeman P (1980) Elevation of brain neuroleptic\/dopamine receptors in schizophrenia. Am J Psychiatry 137:191?197","journal-title":"Am J Psychiatry"},{"key":"CR27","first-page":"877","volume":"19","author":"F Lotstra","year":"1984","unstructured":"Lotstra F, Verbanck P, Mendlewicz J, Vanderhagen JJ (1984) No evidence of antipsychotic effects of caerulein in schizophrenic patients free of neuroleptics: a double-blind crossover study. Biol Psychiatry 19:877?882","journal-title":"Biol Psychiatry"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(84)90043-8","volume":"101","author":"K Matsubara","year":"1984","unstructured":"Matsubara K, Matsushita A (1984) Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol. Eur J Pharmacol 101:157?158","journal-title":"Eur J Pharmacol"},{"key":"CR29","unstructured":"Matsushita A, Itoh S (1982) Pharmacological properties of caerulein, a CCK-8 analogous peptide. Proc World Psychiatric Association, pp 170?173"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00421933","volume":"34","author":"I M\u00f6ller-Nielsen","year":"1974","unstructured":"M\u00f6ller-Nielsen I, Fjalland B, Pedersen V, Nymark M (1974) Pharmacology of neuroleptics upon repeated administration. Psychopharmacologia 34:95?104","journal-title":"Psychopharmacologia"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000468582","volume":"17","author":"T Moroji","year":"1982","unstructured":"Moroji T, Watanabe N, Aoki N, Itoh S (1982) Antipsychotic effects of caerulein, a decapeptide chemically related to cholecystokinin octapeptide in schizophrenia. Int Pharmacopsychiatry 17:255?273","journal-title":"Int Pharmacopsychiatry"},{"key":"CR32","first-page":"134","volume":"19","author":"NPV Nair","year":"1983","unstructured":"Nair NPV, Bloom DM, Nestoros JN, Schwartz G (1983) Therapeutic efficacy of cholecystocinin in neuroleptic-resistant schizophrenic subjects. Pharmacol Bull 19:134?136","journal-title":"Pharmacol Bull"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0278-5846(84)90043-5","volume":"8","author":"NP Nair","year":"1984","unstructured":"Nair NP, Bloom DM, Debonnel G, Schwartz G, Mosticyan S (1984) Cholecystokinin-octapeptide in chronic schizophrenia: a double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 8:711?714","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0278-5846(85)90011-9","volume":"9","author":"NPV Nair","year":"1985","unstructured":"Nair NPV, Lal S, Bloom DM (1985) Cholecystokinin peptides, dopamine and schizophrenia ? a review. Prog Neuropsychopharmacol Biol Psychiatry 9:515?524","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Suppl","key":"CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0196-9781(81)90020-6","volume":"2","author":"WH Oldendorf","year":"1981","unstructured":"Oldendorf WH (1981) Blood-brain barrier permeability to peptides: pitfalls in measurement. Peptides [Suppl] 2:109?111","journal-title":"Peptides"},{"key":"CR36","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1982","unstructured":"Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York"},{"key":"CR37","volume-title":"A stereotaxic atlas of the rat brain","author":"LJ Pellegrino","year":"1979","unstructured":"Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain. Plenum Press, New York"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00690931","volume":"91","author":"E Peselow","year":"1987","unstructured":"Peselow E, Angrist B, Sudilovsky A, Corwin J, Siekierski J, Trent F, Rotrosen J (1987) Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia. Psychopharmacology 91:80?84","journal-title":"Psychopharmacology"},{"key":"CR39","first-page":"443","volume":"21","author":"TD Reisine","year":"1980","unstructured":"Reisine TD, Rosner M, Spokes E, Iversen LL, Yamamura HI (1980) Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue. Adv Biochem Psychopharmacol 21:443?450","journal-title":"Adv Biochem Psychopharmacol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0197-0186(87)90077-5","volume":"10","author":"M Ruggeri","year":"1987","unstructured":"Ruggeri M, Ungerstedt U, Agnati LF, Mutt V, Harfstrand A, Fuxe K (1987) Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anesthetized rat. Neurochem Int 10:509?520","journal-title":"Neurochem Int"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0196-9781(83)90031-1","volume":"4","author":"LH Schneider","year":"1983","unstructured":"Schneider LH, Alpert JE, Iversen SD (1983) CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors. Peptides 4:749?753","journal-title":"Peptides"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0306-4522(81)90002-6","volume":"6","author":"LR Skirbol","year":"1981","unstructured":"Skirbol LR, Grace AA, Hommer DW, Rehfeld J, Goldstein M, Hokfelt T, Bunney BS (1981) Peptide monoamine coexistence: studies of the action of a cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 6:2111?2124","journal-title":"Neuroscience"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00180843","volume":"88","author":"CA Tamminga","year":"1986","unstructured":"Tamminga CA, Littman RL, Alphs LD, Chase TN, Thaker GK, Wagman AM (1986) Neuronal cholecystokinin and schizophrenia: pathogenic and therapeutic studies. Psychopharmacology 88:387?391","journal-title":"Psychopharmacology"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/newbio245262a0","volume":"245","author":"D Tarsy","year":"1973","unstructured":"Tarsy D, Baldessarini BJ (1973) Pharmacologically induced behavioural supersensitivity to apomorphine. Nature New Biol 245:262?263","journal-title":"Nature New Biol"},{"issue":"Suppl 367","key":"CR45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","volume":"83","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971a) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol Scand [Suppl 367] 83:69?93","journal-title":"Acta Physiol Scand"},{"issue":"Suppl 367","key":"CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-201X.1971.tb10999.x","volume":"83","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U (1971b) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand [Suppl 367] 83:49?68","journal-title":"Acta Physiol Scand"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3940(84)90351-3","volume":"52","author":"FJ Vaccarino","year":"1984","unstructured":"Vaccarino FJ, Koob GF (1984) Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward. Neurosci Lett 52:61?66","journal-title":"Neurosci Lett"},{"key":"CR48","first-page":"1273","volume":"13","author":"F Vaccarino","year":"1987","unstructured":"Vaccarino F, Rankin J (1987) Opposite effects of rostral and caudal accumbens CCK microinjections on amphetamine-induced locomotion. Soc Neurosci Abstr 13:1273","journal-title":"Soc Neurosci Abstr"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0014-2999(83)90031-6","volume":"93","author":"JM Ree Van","year":"1983","unstructured":"Van Ree JM, Gaffori O, de Wied D (1983) In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. Eur J Pharmacol 93:63?78","journal-title":"Eur J Pharmacol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6123(08)60213-7","volume":"72","author":"JM Ree Van","year":"1987","unstructured":"Van Ree JM, Verhoeven WM, de Wied D (1987) Animal and clinical research on neuropeptides and schizophrenia. Prog Brain Res 72:249?267","journal-title":"Prog Brain Res"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1523\/JNEUROSCI.05-10-02744.1985","volume":"5","author":"MM Voigt","year":"1988","unstructured":"Voigt MM, Wang RY, Westfall TC (1988) The effects of cholecystokinin on the in vitro release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat. J Neurosci 5:2744?2749","journal-title":"J Neurosci"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0006-8993(86)90236-2","volume":"380","author":"RY Wang","year":"1986","unstructured":"Wang RY, Hu X-T (1986) Does cholecystokinin potentiate dopamine action in the nucleus accumbens? Brain Res 380:363?367","journal-title":"Brain Res"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(84)91352-0","volume":"300","author":"FJ White","year":"1984","unstructured":"White FJ, Wang RJ (1984) Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. Brain Res 300:161?166","journal-title":"Brain Res"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0091-3057(88)90460-1","volume":"30","author":"F Weiss","year":"1988","unstructured":"Weiss F, Tanzer DJ, Ettenberg A (1988) Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats. Pharmacol Biochem Behav 30:309?317","journal-title":"Pharmacol Biochem Behav"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.2878495","volume":"234","author":"DF Wong","year":"1986","unstructured":"Wong DF, Wagner HN Jr, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussole EP, Ravert HT, Wilson AA, Toung JKT, Malat J, Williams JA, O'Tuama LA, Snyder SH, Kuhar MJ, Gjedde A (1986) Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 234:1558?1563","journal-title":"Science"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0028-3908(85)90082-6","volume":"24","author":"G Zetler","year":"1985","unstructured":"Zetler G (1985) Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphineinduced gnawing in sensitized mice. Neuropharmacology 24:251?259","journal-title":"Neuropharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00445568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00445568\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00445568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T01:25:08Z","timestamp":1554341108000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00445568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,11]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,11]]}},"alternative-id":["BF00445568"],"URL":"https:\/\/doi.org\/10.1007\/bf00445568","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,11]]}}}